Human Anti-FGFR4 Recombinant Antibody (clone BM4) (CAT#: HPAB-0062-LS)

The antibody is used to bind the FGF receptor 4 (FGFR4) and the medical use thereof, in particular for the diagnosis prevention or treatment of diseases associated with FGFR expression, overexpression or hyperactivity.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Published Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
FC

Figure 1 Three examples of anti-FGFR4 antibodies bind specifically to FGFR4.

Figure 1 Three examples of anti-FGFR4 antibodies bind specifically to FGFR4.

The binding of antibodies XPA.48.056, XPA.48.117, and XPA.48.148 was evaluated by measuring binding to CHO-hFGFR4 cells (Panel A); HepG2 (Panel B); and HuH7 cells (Panel C) by FACS.

Neut

Figure 2 Three examples of anti-FGFR4 antibodies are capable of neutralizing FGF-19 induced phosphorylation of intracellular proteins. Each of the three example antibodies were able to neutralize pERK (FIG. 4, Panel A) and pGSK-3P (FIG. 4, Panel B) in the presence of a sub-maximal concentration of rfiFGF-19 as measured using electrochemiluminescence.

Figure 2 Three examples of anti-FGFR4 antibodies are capable of neutralizing FGF-19 induced phosphorylation of intracellular proteins. Each of the three example antibodies were able to neutralize pERK (FIG. 4, Panel A) and pGSK-3P (FIG. 4, Panel B) in the presence of a sub-maximal concentration of rfiFGF-19 as measured using electrochemiluminescence.

Each of the three example antibodies were able to neutralize pERK (FIG. 4, Panel A) and pGSK-3P (FIG. 4, Panel B) in the presence of a sub-maximal concentration of rfiFGF-19 as measured using electrochemiluminescence.

ADCC

Figure 3 Three examples of anti-FGFR4 antibodies are capable of mediating antibody-dependent cellular cytotoxicity in HepG2 cells (Panel A), HuH-7 cells (Panel B) and HCT116-FGFR4 cells (Panel C).

Figure 3 Three examples of anti-FGFR4 antibodies are capable of mediating antibody-dependent cellular cytotoxicity in HepG2 cells (Panel A), HuH-7 cells (Panel B) and HCT116-FGFR4 cells (Panel C).

Percent specific cytotoxicity was calculated using 1 or 10 mg/ml antibody.

FC

Figure 4 Three examples of anti-FGFR4 antibodies are capable of binding to mouse FGFR4 in addition to human FGFR4.

Figure 4 Three examples of anti-FGFR4 antibodies are capable of binding to mouse FGFR4 in addition to human FGFR4.

Panel A shows dose-dependent binding of XPA.48.056, XPA.48.117, and XPA.48.148 to endogenous AML12 mouse hepatocytes as measured by flow cytometry. Panel B shows FACS binding of 50 nM XPA.48.056, XPA.48.117, and XPA.48.148 to HEK293E cells transiently transfected with mouse FGFR4 cDNA. Data was normalized to the degree of signal measured for untransfected cells.

FuncS

Figure 5 Three examples of anti-FGFR4 antibodies are capable of inhibiting tumor growth in the HuH-7 xenograft model.

Figure 5 Three examples of anti-FGFR4 antibodies are capable of inhibiting tumor growth in the HuH-7 xenograft model.

Antibodies were administered at 30 mg/kg/week for a total of 4 weeks (15 mice per group).


Specifications

  • Immunogen
  • FGFR4
  • Host Species
  • Human
  • Derivation
  • Phage display library
  • Type
  • Human IgG
  • Specificity
  • Human FGFR4
  • Species Reactivity
  • Human
  • Clone
  • BM4
  • Applications
  • Inhib, ELISA, WB
  • Related Disease
  • Hepatocellular cancer, Breast cancer, Prostate cancer

Product Property

  • Purity
  • >95% as determined by SDS-PAGE and HPLC analysis
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • This antibody has been tested for use in Flow Cytometry, Neutralization, ADCC, Functional Assay.

Target

  • Alternative Names
  • TKF; JTK2; CD334

Related Resources

  • Related Diseases

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone BM4"

See other products for "FGFR4"

Select a product category from the dropdown menu below to view related products.
Please select product type
IgG Antibody Products Mouse Antibody Products Human Antibody Products Rabbit Monoclonal Antibody Products ScFv Antibody Products Fab Antibody Products Neuroscience Antibody Products MHC Tetramer Products for Cancer Antibody Magnetic Beads

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for HPAB-0062-LS. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare